1. Sako EY, Kingsley-Hickman PB, From AH, Ugurbil K, Foker JE. Substrate effects in the post-ischemic myocardium. J Surg Res. 1988. 44:430–435.
2. Stark G, Huber U, Hofer E, Tritthart HA. Continuous ECG measurements of intracardiac activity from the surface of Langendorff-perfused guinea pig hearts. Basic Res Cardiol. 1987. 82:437–444.
3. Tanguay M, Blaise G, Dumont L, Beique G, Hollmann C. Beneficial effects of volatile anesthetics on decrease in coronary flow and myocardial contractility induced by oxygen-derived free radicals in isolated rabbit hearts. J Cardiovasc Pharmacol. 1991. 18:863–870.
4. Batchu SN, Law E, Brocks DR, Falck JR, Seubert JM. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J Mol Cell Cardiol. 2009. 46:67–74.
5. Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM. Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism. Am J Physiol Heart Circ Physiol. 2008. 294:H402–H408.
6. Garcia SC, Pomblum V, Gams E, Langenbach MR, Schipke JD. Independency of myocardial stunning of endothelial stunning? Basic Res Cardiol. 2007. 102:359–367.
7. Lochner A, Genade S, Moolman JA. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol. 2003. 98:337–346.
8. Ofir M, Arad M, Porat E, et al. Increased glycogen stores due to gamma-AMPK overexpression protects against ischemia and reperfusion damage. Biochem Pharmacol. 2008. 75:1482–1491.
9. Gross GJ, Baker JE, Hsu A, Wu HE, Falck JR, Nithipatikom K. Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. Am J Physiol Heart Circ Physiol. 2010. 298:H2201–H2207.
10. Lamberts RR, Onderwater G, Hamdani N, et al. Reactive oxygen species-induced stimulation of 5'AMP-activated protein kinase mediates sevoflurane-induced cardioprotection. Circulation. 2009. 120:11 Suppl. S10–S15.
11. Xi J, McIntosh R, Shen X, et al. Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol. 2009. 47:684–690.
12. Ferrera R, Benhabbouche S, Bopassa JC, Li B, Ovize M. One hour reperfusion is enough to assess function and infarct size with TTC staining in Langendorff rat model. Cardiovasc Drugs Ther. 2009. 23:327–331.
13. Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z. Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology. 2008. 108:243–250.
14. Song DK, Jang Y, Kim JH, Chun KJ, Lee D, Xu Z. Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts. J Korean Med Sci. 2010. 25:380–386.
15. Bouwman RA, Vreden MJ, Hamdani N, et al. Effect of bupivacaine on sevoflurane-induced preconditioning in isolated rat hearts. Eur J Pharmacol. 2010. 647:132–138.
16. Taliyan R, Singh M, Sharma PL, Yadav HN, Sidhu KS. Possible involvement of α1-adrenergic receptor and K(ATP) channels in cardioprotective effect of remote aortic preconditioning in isolated rat heart. J Cardiovasc Dis Res. 2010. 1:145–151.
17. Lee DS, Steinbaugh GE, Quarrie R, et al. Ischemic postconditioning does not provide cardioprotection from long-term ischemic injury in isolated male or female rat hearts. J Surg Res. 2010. 164:175–181.
18. Kolettis TM, Kontaras K, Spartinos I, et al. Dose-dependent effects of sildenafil on post-ischaemic left ventricular function in the rat isolated heart. J Pharm Pharmacol. 2010. 62:346–351.
19. Maslov LN, Lasukova OV, Krylatov AV, et al. Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion. Bull Exp Biol Med. 2006. 142:557–561.
20. Rohlicek CV, Viau S, Trieu P, Hébert TE. Effects of neonatal hypoxia in the rat on inotropic stimulation of the adult heart. Cardiovasc Res. 2005. 65:861–868.
21. Gelpi RJ, Morales C, Cohen MV, Downey JM. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol. 2002. 97:40–46.
22. Chen HT, Yang CX, Li H, et al. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts. Acta Pharmacol Sin. 2008. 29:931–941.